A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors.

Stacy L Moulder; John J Mahany; Richard Lush; Caio Rocha-Lima; Michael Langevin; Karen J Ferrante; Lisa Michele Bartkowski; Shama M Kajiji; Dennis A Noe; Simone Paillet

doi:10.1158/1078-0432.CCR-04-0901

A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors.

Identifier:nobleid.org/w1/20260515/C7FDBA42

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C7FDBA42.svg?ark=w1%2F20260515%2FC7FDBA42)](https://nobleid.org/work/w1/20260515/C7FDBA42)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Lisa Michele Bartkowski

Shama M Kajiji

Dennis A Noe

Simone Paillet

Claim authorship of this work

A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors.

Identifier:nobleid.org/w1/20260515/C7FDBA42

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C7FDBA42.svg?ark=w1%2F20260515%2FC7FDBA42)](https://nobleid.org/work/w1/20260515/C7FDBA42)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Lisa Michele Bartkowski

Shama M Kajiji

Dennis A Noe

Simone Paillet

Claim authorship of this work